Gary Matoren lost his daughter at the age of nine. Debbie Lynn was born with a heart defect he said was due to a drug his wife was prescribed for morning sickness. As a result, Matoren dedicated his career to healthcare fields such as pharmacy, administration and clinical research. He is now creating a legacy at Stony Brook by leaving his estate to help graduate students continue their pursuit of researching and discovering ways to prevent genetic disorders.
Throughout his career, Matoren focused on drug toxicity and the etiology of disease. He edited a book, The Clinical Research Process in the Pharmaceutical Industry, and founded the journal Clinical Research Practices and Drug Regulatory Affairs. “I stayed in the pharmaceutical healthcare field because of my youngest daughter Debbie Lynn,” said Matoren.
Matoren’s family has been the inspiration behind his philanthropy. He has decided to leave his entire estate to Stony Brook University in the form of two fellowships and a scholarship. “I live a frugal lifestyle,” said Matoren. “And I want to give back to students to help them achieve their goals and further advance clinical research.”
“We are honored that Gary chose Stony Brook as the place for his remarkable philanthropic legacy,” said Scott Barrett, interim vice president for University Advancement. “This extraordinary gift represents more than just a visionary commitment — it establishes a perpetual support for students and their research.”
Read the full story by Christine McGrath at SB Matters.
Add comment